drugset / Trial / NCT00003466

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

NCT00003466 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with progressive low-grade glioma.

Timeline

Start
1998-03
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral